+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Syros Pharmaceuticals Inc (SYRS) - Financial and Strategic SWOT Analysis Review

  • ID: 4278351
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.


Syros Pharmaceuticals Inc (Syros) is a biopharmaceutical company which develops medicines for the treatment of cancer, immune-mediated diseases, and other diseases. The company’s pipeline products include SY-1425, an oral, potent and selective RARa agonist that are used to treat patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It also provides SY-1365, potent and selective small molecule inhibitor of CDK7 that are used to treat patients with transcriptionally driven solid tumors and acute leukemias. Syors offers services such as gene regulation, new medicines development, genes control, proprietary drug development platform, integrated gene control assay technologies, and computational biology, chemistry, and deep biologic insights solutions. Its gene control platform identifies novel gene control targets linked to genomically defined patient populations, and drugging gene control targets. The company seeks to work in partnership with others biopharmaceutical companies to extend the potential of our gene control platform across multiple therapeutic areas and diseases. Syros is headquartered in Cambridge, Massachusetts, the US.

Syros Pharmaceuticals Inc Key Recent Developments

Jan 08, 2018: Syros Announces 2018 Strategic Priorities and Expected Milestones
Nov 13, 2017: Syros Announces Appointment of Jeremy P. Springhorn as Chief Business Officer
Nov 08, 2017: Syros Reports Third Quarter 2017 Financial Results and Highlights Accomplishments and Upcoming Milestones
Oct 26, 2017: Syros’ Drug Discovery Research in Immuno-Oncology Highlighted in Oral Presentation at American College of Surgeons Clinical Congress
Oct 20, 2017: Syros Announces Oral Presentation Highlighting Its Drug Discovery Research in Immuno-Oncology at American College of Surgeons Clinical Congress

This comprehensive SWOT profile of Syros Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Syros Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
Section 1 - About the Company
  • Syros Pharmaceuticals Inc - Key Information
  • Syros Pharmaceuticals Inc - Overview
  • Syros Pharmaceuticals Inc - Key Employees
  • Syros Pharmaceuticals Inc - Key Employee Biographies
  • Syros Pharmaceuticals Inc - Key Operational Heads
  • Syros Pharmaceuticals Inc - Major Products and Services
  • Syros Pharmaceuticals Inc - History
  • Syros Pharmaceuticals Inc - Company Statement
  • Syros Pharmaceuticals Inc - Locations And Subsidiaries
  • Syros Pharmaceuticals Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Syros Pharmaceuticals Inc - Business Description
  • Syros Pharmaceuticals Inc - Corporate Strategy
  • Syros Pharmaceuticals Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Syros Pharmaceuticals Inc - Strengths
  • Syros Pharmaceuticals Inc - Weaknesses
  • Syros Pharmaceuticals Inc - Opportunities
  • Syros Pharmaceuticals Inc - Threats
  • Syros Pharmaceuticals Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Syros Pharmaceuticals Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Syros Pharmaceuticals Inc, Key Information
  • Syros Pharmaceuticals Inc, Key Ratios
  • Syros Pharmaceuticals Inc, Share Data
  • Syros Pharmaceuticals Inc, Major Products and Services
  • Syros Pharmaceuticals Inc, History
  • Syros Pharmaceuticals Inc, Key Employees
  • Syros Pharmaceuticals Inc, Key Employee Biographies
  • Syros Pharmaceuticals Inc, Key Operational Heads
  • Syros Pharmaceuticals Inc, Other Locations
  • Syros Pharmaceuticals Inc, Subsidiaries
  • Syros Pharmaceuticals Inc, Key Manufacturing facilities
  • Syros Pharmaceuticals Inc, Key Competitors
  • Syros Pharmaceuticals Inc, SWOT Analysis
  • Syros Pharmaceuticals Inc, Ratios based on current share price
  • Syros Pharmaceuticals Inc, Annual Ratios
  • Syros Pharmaceuticals Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Syros Pharmaceuticals Inc, Performance Chart
  • Syros Pharmaceuticals Inc, Ratio Charts
Note: Product cover images may vary from those shown